Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.

about

Metabolic Disorders in Chronic Lung Diseases.Lung Transplantation in Idiopathic Pulmonary Fibrosis

P2860

Q49795481-FB010C53-A48A-478E-8567-939459B41560 Q58710324-0E168879-E9E0-4144-8DA4-76ECE85C46C3

P2860

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.

Item

http://www.wikidata.org/entity/Q38616538

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.

@en

type

Item

label

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.

@en

prefLabel

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.

@en

P1476

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.

@en

P2093

Harold R Collard

http://www.w3.org/2001/XMLSchema#string

Justin M Oldham

http://www.w3.org/2001/XMLSchema#string

P2860

Screening for Coronary Heart Disease With Electrocardiography: U.S. Preventive Services Task Force Recommendation Statement

Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

Reduced lung-cancer mortality with low-dose computed tomographic screening

A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis

Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis

P304

123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FMED.2017.00123

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28824912

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

5539138

http://www.w3.org/2001/XMLSchema#string

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.

about

P2860

P2860

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932